查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1721575

消融设备市场机会、成长动力、产业趋势分析及 2025 - 2034 年预测

Ablation Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
出版日期: | 出版商: Global Market Insights Inc. | 英文 130 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024 年全球消融设备市场价值为 110 亿美元，预计到 2034 年将以 8.1% 的复合年增长率成长，达到 248 亿美元。由于全球癌症和心血管疾病等慢性疾病负担日益加重，消融设备的需求持续上升。随着世界各地的医疗保健系统优先考虑能够以更快的恢復时间提供目标结果的微创解决方案，消融技术已成为首选的治疗方法。医院和诊所正积极采用这些设备，为患者提供比传统手术更有效的替代方案。患者和医疗专业人员对能量治疗益处的认识不断提高，进一步推动了市场的发展。

消融设备市场 - IMG1

持续的技术进步，加上支持性监管框架，使得消融设备更容易取得且价格更实惠。政府和医疗机构也认识到消融技术在减少住院时间和整体治疗成本方面的作用，这加速了其融入主流护理。此外，门诊手术的增加和个人化医疗的推动为产品创新和针对患者的治疗计划开闢了新的途径。随着精准医疗需求的增加，製造商正在大力投资研发，将更智慧、更安全、更适应性的消融解决方案推向市场。

市场范围
起始年份 2024
预测年份 2025-2034
起始值 110亿美元
预测值 248亿美元
复合年增长率 8.1%

消融设备是一种专门的医疗器械，旨在透过聚焦能量传输来去除或破坏异常组织。这些设备在提供精确、可控的治疗方案的同时，对周围健康组织的损害最小，并发挥关键作用。该市场拥有广泛的技术，包括射频、雷射/光、超音波、冷冻消融等，每种技术都根据临床需求和患者情况具有独特的优势。

2024 年，射频设备领域占据全球消融设备市场的 49.2% 主导份额，预计未来几年仍将保持这一领先地位。这项优势很大程度上归功于该技术在治疗癌症和心律不整等慢性疾病方面日益广泛的应用。射频消融术（RFA）因其微创性和高治疗效果而受到广泛认可，成为医生的首选。 RFA 技术的持续进步，包括更精确的定位和增强的安全性，正在进一步推动其应用。

消融设备广泛应用于各种医疗应用，包括心臟病学、肿瘤学、妇科、泌尿科、眼科和整容手术。 2024 年，光是心臟病学领域就创造了 45 亿美元的收入，这得益于老龄人口的增长和非侵入性心臟治疗需求的不断增长。先进影像技术支援的早期诊断使患者能够及时接受治疗，而强有力的医生建议则继续增加城市和农村医疗保健环境中的手术量。

预计到 2034 年，美国消融设备市场规模将达到 89 亿美元。美国 FDA 的快速审批流程以及优惠的医疗保险和私人保险公司报销政策大大提高了患者的就医机会，并鼓励供应商扩大其治疗范围。

全球消融设备产业的主要参与者包括 CONMED Corporation、美敦力、波士顿科学公司、强生公司、施乐辉公司、奥林巴斯公司、Biosense Webster 公司、AngioDynamics 公司、雅培实验室和瓦里安医疗系统公司。这些公司专注于透过合作、收购和推出脉衝场消融系统等下一代技术来实现策略性成长。透过与研究机构合作并投资先进的设备开发，他们旨在提供更安全、更有效的消融解决方案并加强其全球影响力。

目录

第一章：方法论与范围

第二章：执行摘要

第三章：行业洞察

  • 产业生态系统分析
  • 产业衝击力
    • 成长动力
      • 慢性病盛行率不断上升
      • 消融设备的技术进步
      • 微创手术需求不断成长
      • 老年人口基数不断增加
    • 产业陷阱与挑战
      • 消融手术风险高
      • 严格的监管审批
  • 成长潜力分析
  • 监管格局
  • 技术格局
  • 未来市场趋势
  • 差距分析
  • 专利分析
  • 波特的分析
  • PESTEL分析

第四章：竞争格局

  • 介绍
  • 公司市占率分析
  • 公司矩阵分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 策略仪表板

第五章：市场估计与预测：按技术，2021 年至 2034 年

  • 主要趋势
  • 射频设备
  • 雷射/光消融
  • 超音波设备
  • 冷冻消融设备
  • 其他技术

第六章：市场估计与预测：按应用，2021 年至 2034 年

  • 主要趋势
  • 心臟病学
  • 肿瘤学
  • 眼科
  • 妇科
  • 泌尿科
  • 整容手术
  • 其他应用

第七章：市场估计与预测：依最终用途，2021 年至 2034 年

  • 主要趋势
  • 医院
  • 门诊手术中心
  • 其他最终用途

第八章：市场估计与预测：按地区，2021 年至 2034 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 俄罗斯
    • 波兰
    • 瑞士
    • 荷兰
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 韩国
    • 泰国
    • 印尼
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 智利
  • 中东和非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿联酋
    • 以色列

第九章：公司简介

  • Abbott Laboratories
  • Alcon Laboratories
  • Angiodynamics
  • Atricure
  • Bausch & Lomb
  • Biotronik
  • Boston Scientific
  • CONMED
  • Elekta
  • Ethicon
  • Medtronic
  • Olympus
  • Varian
简介目录
Product Code: 3419

The Global Ablation Devices Market was valued at USD 11 billion in 2024 and is estimated to grow at a CAGR of 8.1% to reach USD 24.8 billion by 2034. The demand for ablation devices continues to rise, fueled by the increasing global burden of chronic diseases like cancer and cardiovascular conditions. As healthcare systems worldwide prioritize minimally invasive solutions that deliver targeted results with faster recovery times, ablation technology has emerged as a go-to treatment method. Hospitals and clinics are actively adopting these devices to offer patients more efficient alternatives to traditional surgery. The growing awareness among patients and medical professionals about the benefits of energy-based treatments has further pushed the market forward.

Ablation Devices Market - IMG1

Ongoing technological advancements, combined with supportive regulatory frameworks, are making ablation devices more accessible and affordable. Governments and healthcare bodies are also recognizing the role of ablation technologies in reducing hospital stays and overall treatment costs, which is accelerating their integration into mainstream care. Additionally, the rise in outpatient procedures and the push toward personalized healthcare have opened new avenues for product innovation and patient-specific treatment planning. As the demand for precision medicine increases, manufacturers are investing heavily in R&D to bring smarter, safer, and more adaptable ablation solutions to market.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$11 Billion
Forecast Value$24.8 Billion
CAGR8.1%

Ablation devices are specialized medical instruments designed to remove or destroy abnormal tissues through focused energy delivery. These devices play a critical role in offering precise and controlled treatment options with minimal damage to surrounding healthy tissue. The market features a broad range of technologies, including radiofrequency, laser/light, ultrasound, cryoablation, and more-each with unique advantages based on clinical needs and patient profiles.

The radiofrequency devices segment held a dominant 49.2% share of the global ablation devices market in 2024 and is expected to maintain this lead in the years ahead. This stronghold is largely attributed to the technology's growing use in treating chronic conditions like cancer and cardiac arrhythmias. Radiofrequency ablation (RFA) is widely recognized for its minimally invasive nature and high treatment efficacy, making it a preferred choice among physicians. Continued advancements in RFA technology, including more precise targeting and enhanced safety profiles, are further driving adoption.

Ablation devices are widely used in various medical applications, including cardiology, oncology, gynecology, urology, ophthalmology, and cosmetic surgery. In 2024, the cardiology segment alone generated USD 4.5 billion, driven by a rising elderly population and the growing demand for non-invasive cardiac treatments. Early diagnosis supported by advanced imaging technologies has empowered patients to pursue timely treatment, while strong physician recommendations continue to boost procedure volumes in both urban and rural healthcare settings.

The U.S. Ablation Devices Market is projected to reach USD 8.9 billion by 2034. The U.S. FDA's fast-track approval processes and favorable Medicare and private insurer reimbursement policies have significantly enhanced patient access and encouraged providers to broaden their treatment offerings.

Key players in the global ablation devices industry include CONMED Corporation, Medtronic, Boston Scientific Corporation, Johnson & Johnson, Smith & Nephew plc, Olympus Corporation, Biosense Webster, Inc., AngioDynamics, Inc., Abbott Laboratories, and Varian Medical Systems Inc. These companies are focused on strategic growth through partnerships, acquisitions, and the launch of next-gen technologies like pulsed-field ablation systems. By collaborating with research institutions and investing in advanced device development, they aim to deliver safer, more effective ablation solutions and strengthen their global footprint.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° Synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of chronic diseases
      • 3.2.1.2 Technological advancements in ablation devices
      • 3.2.1.3 Rising demand for minimally invasive procedures
      • 3.2.1.4 Growing geriatric population base
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High risk associated with ablation procedures
      • 3.2.2.2 Stringent regulatory approvals
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technological landscape
  • 3.6 Future market trends
  • 3.7 Gap analysis
  • 3.8 Patent analysis
  • 3.9 Porter’s analysis
  • 3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Technology, 2021 – 2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 Radiofrequency devices
  • 5.3 Laser/light ablation
  • 5.4 Ultrasound devices
  • 5.5 Cryoablation devices
  • 5.6 Other technologies

Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 Cardiology
  • 6.3 Oncology
  • 6.4 Ophthalmology
  • 6.5 Gynecology
  • 6.6 Urology
  • 6.7 Cosmetic surgery
  • 6.8 Other applications

Chapter 7 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 Hospitals
  • 7.3 Ambulatory surgical centers
  • 7.4 Other end use

Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Russia
    • 8.3.7 Poland
    • 8.3.8 Switzerland
    • 8.3.9 Netherlands
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 India
    • 8.4.3 Japan
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Thailand
    • 8.4.7 Indonesia
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
    • 8.5.4 Columbia
    • 8.5.5 Chile
  • 8.6 Middle East and Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 South Africa
    • 8.6.3 UAE
    • 8.6.4 Israel

Chapter 9 Company Profiles

  • 9.1 Abbott Laboratories
  • 9.2 Alcon Laboratories
  • 9.3 Angiodynamics
  • 9.4 Atricure
  • 9.5 Bausch & Lomb
  • 9.6 Biotronik
  • 9.7 Boston Scientific
  • 9.8 CONMED
  • 9.9 Elekta
  • 9.10 Ethicon
  • 9.11 Medtronic
  • 9.12 Olympus
  • 9.13 Varian